Systematic review Meta-analysis Efficacy and tolerability of renzapride in irritable bowel - Antagonist - Document - PDFSEARCH.IO

First Page		Document Content
Science Bioethics Medical ethics Pharmacology Design of experiments Irritable bowel syndrome Placebo Probiotic 5-HT3 antagonist Medicine Health Clinical research		Systematic review/Meta-analysis Efficacy and tolerability of renzapride in irritable bowel Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 474,06 KB Share Document on Facebook

	P11444 - ASCO2014 MEC and HEC DocID: 1a4Ek - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 19OCx - View Document
	Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella DocID: 19AF1 - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 199Dl - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 1987o - View Document